DjamgaMind Health Intelligence: Canada Series

DjamgaMind
DjamgaMind
  • 0.0 (0)
  • Medicine
  • Updated Biweekly

The premium audio intelligence briefing for Canadian Hospital Executives. We decode Bill C-27's replacement, AIDA, and Health Canada mandates into actionable 5-minute briefings. Designed for the commute of the busy CIO. Member Only: This is a private feed for DjamgaMind subscribers.

$9.99/mo or $99.99/yr after trial

Episodes

  1. Mar 24 • Subscribers Only

    [HEALTH INTEL CANADA] Forensic Briefing: The 2026 PMPRB Guidelines and Canada's "Tier 3" Drug Market

    🚀 Welcome to DjamgaMind. Summary: This DjamgaMind Special performs a macroeconomic autopsy on Canada’s newly activated "Guidelines for PMPRB Staff." We move past the political talking points to identify the fatal flaw of the PMPRB11 basket: the "Global Referencing Contagion." This episode explores the new Two-Step Review Process, the danger of the Therapeutic Class Comparison (TCC), and why international biotech firms are actively choosing to cancel the launch of life-saving orphan drugs in Canada to protect their global pricing models. Key Intelligence Covered: The Two-Step Process: A technical breakdown of the Initial/Annual screening and the rigorous In-Depth Review. The PMPRB11 Squeeze: How the removal of the US and Switzerland artificially lowers the Highest International Price (HIP) threshold. Global Referencing Contagion: The forensic math of why launching a drug at a heavy discount in Canada destroys a pharmaceutical company's global revenue. The Galderma Effect: How recent legal pushback stripped the PMPRB of its "clinical similarity" jurisdiction, and how the board is adjusting its tactics. The "Launch Delay" Crisis: Why Canada has become a "Tier 3" launch market, leaving Canadian patients waiting years for breakthrough treatments. Strategic Signal: Local Price Controls as a Global Launch Deterrent. Keywords: PMPRB 2026 Guidelines, Patented Medicine Prices Review Board, PMPRB11, Highest International Price (HIP), Two-Step Review Process, Global Referencing Contagion, Drug Pricing Canada, Therapeutic Class Comparison (TCC), Galderma Decision, Health Canada Regulation, DjamgaMind, Etienne Noumen, Regulatory Forensics. 🎙️ DjamgaMind: Tired of the ads? Get the forensic version of this news. Join our Ads-FREE Premium Feed at DjamgaMind. Technical, deep, and uninterrupted. 👉 Switch to Ads-Free: DjamgaMind on Apple Podcasts Contact us etienne_noumen@djamgamind.com Connect with Etienne Noumen: https://www.linkedin.com/in/enoumen/ Partner with us: https://djamgamind.com/partners ⚗️ PRODUCTION NOTE: We Practice What We Preach. AI Unraveled is produced using a hybrid "Human-in-the-Loop" workflow. While all research, interviews, and strategic insights are curated by Etienne Noumen, we leverage advanced AI voice synthesis for our daily narration to ensure speed, consistency, and scale.

    [HEALTH INTEL CANADA] Forensic Briefing: The 2026 PMPRB Guidelines and Canada's "Tier 3" Drug Market

  2. Mar 19 • Subscribers Only

    [HEALTH INTEL CANADA] Forensic Briefing: Ontario’s Connected Care Act and the End of Data Silos

    🚀 Welcome to DjamgaMind. Summary: This DjamgaMind Special performs a technical autopsy on Ontario’s health data mandates (Bill 135 / Connecting Care Act). We deconstruct the "Anti-Blocking" rules designed to force legacy EMR vendors to open their systems. This episode explores the "Data Sovereign" drama where US startups face market exclusion for failing to meet Canadian-specific interoperability standards and the rising personal liability for CIOs who fail to prioritize data flow. Key Intelligence Covered: Ontario Health atHome: Analyzing the new centralized service organization and its role as the data hub for home and community care. The Anti-Blocking Mandate: How Ontario is legally prohibiting vendors from interfering with the secure exchange of personal health information. US Startup Crash: A forensic look at why "HIPAA-compliant" is no longer "Canada-ready" in the age of Connected Care. Personal Liability: The high-stakes shift where CIOs can be held personally accountable for "Data Silo" maintenance under updated PHIPA enforcement powers. Strategic Signal: Provincial Data Sovereignty as a Market Barrier. Keywords: Connected Care Act Ontario, Bill 135 Ontario, Connecting Care Act 2019, Data Blocking Healthcare, Ontario Health atHome, Health Data Interoperability, PHIPA Enforcement, CIO Personal Liability, Clinical Data Repository (CDR), FHIR Canada Profiles, DjamgaMind, Etienne Noumen. 🎙️ DjamgaMind: Tired of the ads? Get the forensic version of this news. Join our Ads-FREE Premium Feed at DjamgaMind. Technical, deep, and uninterrupted. 👉 Switch to Ads-Free: DjamgaMind on Apple Podcasts Contact us etienne_noumen@djamgamind.com Connect with Etienne Noumen: https://www.linkedin.com/in/enoumen/ Partner with us: https://djamgamind.com/partners ⚗️ PRODUCTION NOTE: We Practice What We Preach. AI Unraveled is produced using a hybrid "Human-in-the-Loop" workflow. While all research, interviews, and strategic insights are curated by Etienne Noumen, we leverage advanced AI voice synthesis for our daily narration to ensure speed, consistency, and scale.

    [HEALTH INTEL CANADA] Forensic Briefing: Ontario’s Connected Care Act and the End of Data Silos

  3. Mar 15 • Subscribers Only

    Alberta HIA: Can You Legally Put Patient Data in the US Cloud?

    Is your hospital’s cloud strategy breaking the law? In this episode of the DjamgaMind Canada Series, we simulate a high-stakes debate between a frustrated Hospital CIO and a strict Privacy Commissioner regarding the Alberta Health Information Act (HIA). The central question: Can you legally process Alberta patient data on US servers (AWS, Google, Azure)? Most founders and executives think the answer is a hard "No." The reality is a complicated "Maybe"—but only if you navigate the minefield of Section 60. We decode: The "US Cloud" Myth: Does the HIA explicitly ban data from leaving Canada? (The answer will surprise you). Section 60 Explained: The specific legal requirements for "disclosing" health information outside of Alberta. The PIA Trap: Why deploying any new tool without a Privacy Impact Assessment is a direct violation of the Act. Data Sovereignty vs. Residency: The critical difference between where data "lives" and whose laws it obeys. The Custodian Trap: Why the hospital (Custodian) carries 100% of the liability, even if the vendor (Information Manager) causes the breach. Source Document: Alberta Health Information Act (HIA) - Official Text About DjamgaMind: DjamgaMind is the AI-powered audio intelligence platform for Healthcare Executives. We turn complex regulations (Bill C-27, HIA, CMS-0057-F) into 10-minute executive briefings. 🔗 Subscribe for the full intelligence feed: DjamgaMind.com Keywords / Tags (For Transistor Settings) Alberta Health Information Act, HIA, OIPC Alberta, Privacy Impact Assessment, PIA, Data Residency, Digital Health Canada, AHS Compliance, Hospital CIO, Calgary Tech, Section 60, US Cloud Act Note: This episode features AI-generated hosts simulating a strategic debate based on the official legal text of the HIA.

    Alberta HIA: Can You Legally Put Patient Data in the US Cloud?
  • 3 Episodes

Shows with Subscription Benefits

CLEAN AUDIO INTELLIGENCE

Get exclusive episodes, early access, and more

$9.99/mo or $99.99/yr after trial

View Subscription FAQs

About

The premium audio intelligence briefing for Canadian Hospital Executives. We decode Bill C-27's replacement, AIDA, and Health Canada mandates into actionable 5-minute briefings. Designed for the commute of the busy CIO. Member Only: This is a private feed for DjamgaMind subscribers.

Information

More From DjamgaMind